Literature DB >> 26542658

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.

Henry R Black, Domenic Sica, Keith Ferdinand, William B White.   

Abstract

Entities:  

Keywords:  ACC/AHA Scientific Statements; athletes; blood pressure measurement; cardiovascular abnormalities; hypertension

Mesh：

Year:  2015        PMID： 26542658     DOI： 10.1016/j.jacc.2015.09.038

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  6 in total

1.  Interassociation Consensus Statement on Cardiovascular Care of College Student-Athletes.

Authors:  Brian Hainline; Jonathan Drezner; Aaron Baggish; Kimberly G Harmon; Michael S Emery; Robert J Myerburg; Eduardo Sanchez; Silvana Molossi; John T Parsons; Paul D Thompson
Journal:  J Athl Train       Date:  2016-04-25       Impact factor: 2.860

Review 2.  Approach to Hypertension in Adolescents and Young Adults.

Authors:  Seyed Mehrdad Hamrahian; Bonita Falkner
Journal:  Curr Cardiol Rep       Date:  2022-01-08       Impact factor: 2.931

Review 3.  Updated Blood Pressure Guidelines: Implications for Athletes.

Authors:  Wesley Ghasem; Christiane Abouzeid; Brett G Toresdahl; Ankit B Shah
Journal:  Curr Hypertens Rep       Date:  2022-07-05       Impact factor: 4.592

4.  Pre-participation Cardiovascular Screening in Young Competitive Athletes.

Authors:  Bradley J Petek; Aaron L Baggish
Journal:  Curr Emerg Hosp Med Rep       Date:  2020-05-21

Review 5.  Monitoring and management of hypertension with obesity in adolescents.

Authors:  Bonita Falkner
Journal:  Integr Blood Press Control       Date:  2017-11-20

6.  The Optimal Range of Serum Uric Acid for Cardiometabolic Diseases: A 5-Year Japanese Cohort Study.

Authors:  Masanari Kuwabara; Ichiro Hisatome; Koichiro Niwa; Petter Bjornstad; Carlos A Roncal-Jimenez; Ana Andres-Hernando; Mehmet Kanbay; Richard J Johnson; Miguel A Lanaspa
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.